This site is intended for healthcare professionals
News

FDA approves CAR T cell therapy Tecartus for mantle cell lymphoma.- Kite Pharma/Gilead Sciences

Read time: 1 mins
Last updated:27th Jul 2020
Published:25th Jul 2020
Condition: Mantle Cell Lymphoma
Type: drug
Register free for full access to medthority.com